The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lipman Andrew D since 2010.
This trader's CIK number is 1184208.
At the time of last reporting, Lipman Andrew D was the Director of Nu Skin Enterprises, Inc.. (stock ticker symbol NUS).
Also see all insider trading activities at Nu Skin Enterprises, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | NUS | 0 | $0 | 10,000 | $138,000 | 0 | $0 |
| 2023 | NUS | 0 | $0 | 37,400 | $910,981 | 0 | $0 |
| 2022 | NUS | 0 | $0 | 11,000 | $486,660 | 0 | $0 |
| 2019 | NUS | 0 | $0 | 0 | $0 | 20,100 | $379,790 |
| 2018 | NUS | 0 | $0 | 0 | $0 | 10,000 | $264,700 |
| 2017 | NUS | 0 | $0 | 0 | $0 | 10,000 | $228,850 |
| 2016 | NUS | 0 | $0 | 30,000 | $1,923,899 | 10,000 | $170,400 |
| 2015 | NUS | 0 | $0 | 0 | $0 | 10,000 | $222,500 |
| 2014 | NUS | 0 | $0 | 0 | $0 | 17,500 | $330,300 |
| 2013 | NUS | 0 | $0 | 0 | $0 | 10,000 | $99,600 |
| 2011 | NUS | 0 | $0 | 5,000 | $159,600 | 7,500 | $51,750 |
| 2010 | NUS | 0 | $0 | 0 | $0 | 7,500 | $55,800 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-05-28 | NUS | Sale | 2,000 | 13.33 | 26,660 |
| 2024-04-25 | NUS | Sale | 2,000 | 12.34 | 24,680 |
| 2024-03-25 | NUS | Sale | 2,000 | 12.32 | 24,640 |
| 2024-02-26 | NUS | Sale | 2,000 | 12.46 | 24,920 |
| 2024-01-25 | NUS | Sale | 2,000 | 18.55 | 37,100 |
| 2023-12-26 | NUS | Sale | 2,000 | 19.39 | 38,780 |
| 2023-11-27 | NUS | Sale | 2,000 | 17.11 | 34,220 |
| 2023-11-03 | NUS | Sale | 15,400 | 17.68 | 272,272 |
| 2023-10-25 | NUS | Sale | 2,000 | 19.23 | 38,460 |
| 2023-09-25 | NUS | Sale | 2,000 | 23.02 | 46,040 |
| 2023-08-25 | NUS | Sale | 2,000 | 23.33 | 46,660 |
| 2023-07-25 | NUS | Sale | 2,000 | 28.99 | 57,980 |
| 2023-06-26 | NUS | Sale | 2,000 | 32.12 | 64,239 |
| 2023-05-25 | NUS | Sale | 2,000 | 34.28 | 68,560 |
| 2023-04-25 | NUS | Sale | 2,000 | 40.75 | 81,500 |
| 2023-03-27 | NUS | Sale | 2,000 | 39.29 | 78,580 |
| 2023-02-22 | NUS | Sale | 1,000 | 41.42 | 41,420 |
| 2023-01-23 | NUS | Sale | 1,000 | 42.27 | 42,270 |
| 2022-11-22 | NUS | Sale | 1,000 | 38.16 | 38,160 |
| 2022-10-21 | NUS | Sale | 1,000 | 35.92 | 35,920 |
| 2022-09-22 | NUS | Sale | 1,000 | 36.67 | 36,670 |
| 2022-08-22 | NUS | Sale | 1,000 | 45.01 | 45,010 |
| 2022-07-22 | NUS | Sale | 1,000 | 43.00 | 43,000 |
| 2022-06-22 | NUS | Sale | 1,000 | 44.06 | 44,060 |
| 2022-05-23 | NUS | Sale | 1,000 | 44.95 | 44,950 |
| 2022-04-22 | NUS | Sale | 1,000 | 47.72 | 47,720 |
| 2022-03-22 | NUS | Sale | 1,000 | 47.40 | 47,400 |
| 2022-02-22 | NUS | Sale | 1,000 | 53.27 | 53,270 |
| 2022-01-24 | NUS | Sale | 1,000 | 50.50 | 50,500 |
| 2019-05-21 | NUS | Option Ex | 5,000 | 43.20 | 216,000 |
| 2019-05-18 | NUS | Option Ex | 5,000 | 13.77 | 68,850 |
| 2019-02-27 | NUS | Option Ex | 10,100 | 9.40 | 94,940 |
| 2018-06-25 | NUS | Option Ex | 5,000 | 15.75 | 78,750 |
| 2018-05-24 | NUS | Option Ex | 5,000 | 37.19 | 185,950 |
| 2017-05-26 | NUS | Option Ex | 5,000 | 28.01 | 140,050 |
| 2017-05-13 | NUS | Option Ex | 5,000 | 17.76 | 88,800 |
| 2016-09-22 | NUS | Sale | 30,000 | 64.13 | 1,923,899 |
| 2016-05-18 | NUS | Option Ex | 10,000 | 17.04 | 170,400 |
| 2015-05-13 | NUS | Option Ex | 10,000 | 22.25 | 222,500 |
| 2014-04-16 | NUS | Option Ex | 10,000 | 23.28 | 232,800 |
| 2012-03-08 | NUS | Option Ex | 7,500 | 13.00 | 97,500 |
| 2013-04-02 | NUS | Option Ex | 10,000 | 9.96 | 99,600 |
| 2011-02-18 | NUS | Sale | 5,000 | 31.92 | 159,600 |
| 2011-02-15 | NUS | Option Ex | 7,500 | 6.90 | 51,750 |
| 2010-02-17 | NUS | Option Ex | 7,500 | 7.44 | 55,800 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lipman Andrew D (Director of Nu Skin Enterprises, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.